Bussiness Ideas

NeuraCardia AI is a deeptech health startup focused on transforming the way cardiac conditions are diagnosed, monitored, and managed — especially during critical emergencies and post-surgical recovery. Our core innovation lies in a wearable, non-invasive biosensing device that uses aptamer-based microneedle technology to continuously monitor cardiac biomarkers like Troponin I, CK-MB, and Myoglobin directly from interstitial fluid (ISF). Unlike traditional diagnostics that rely on painful, repetitive blood tests and centralized lab infrastructure, our device allows real-time, painless, continuous monitoring of heart health using a single-use microneedle patch and a reusable, wireless-enabled reader. The collected data is processed through an AI-driven analytics engine that tracks trends, detects anomalies, and predicts cardiac risks — delivering alerts to doctors and caregivers via a cloud-based dashboard or mobile interface. NeuraCardia AI targets ICUs, ambulance services, post-operative recovery wards, home healthcare setups, and rural/PHC environments where lab access is limited. The business operates on a hybrid B2B and B2G model, offering device bundles to hospitals, emergency services, and government health programs, with potential SaaS-style AI dashboards for long-term cardiac monitoring and predictive analytics. By replacing conventional diagnostics with a scalable, AI-integrated wearable platform, NeuraCardia AI aims to reduce diagnosis delays, improve emergency response, and enhance clinical decision-making — creating impact across both urban and underserved geographies.

Startup Teams

• 1 Priyansh Kumar Sharma (Director)
• 2 Jyotasana Apoorva (Director)
• 3 Dr. Ujjawal Pundir (Director)

Incubation Details

• Incubator Name
  Centre for Medical Innovation and incubation -(CMII-GIMS)
• Incubator Host Institution
  Government Institute of Medical Sciences
• State
  Uttar Pradesh
• City
  Gautam Buddha Nagar